Usted buscó: guidance (Griego - Inglés)

Διαχειριστής ενέργειας guidance
guidance power manager

note for guidance on specifications:
note for guidance on specifications:

note for guidance on the clinical
core spc for human albumin released for consultation june 2000 note for guidance on the clinical investigation of plasma derived antithrombin products released for consultation december 2000

note for guidance on carcinogenic potential
note for guidance on carcinogenic potential

03 Αρχές της Εκπαίδευσης beratung guidance
s/ desarrollo de la personalidad uf ego growth uf individual development bt1 mental development nt1 individualization

for guidance on plasma- derived medicinal
revision of section 3.2.5 of cpmp note for guidance on plasma-derived medicinal products released for consultation july 2000

guidance for the statistical classification of customers .
guidance for the statistical classification of customers .

update of note for guidance on carcinogenic potential
update of note for guidance on carcinogenic potential

note for guidance on requirements for pharmaceutical documentation for
note for guidance on requirements for pharmaceutical documentation for pressurised metered dose inhalation products released for consultation november 2000

note for guidance on medicinal gases – pharmaceutical information
note for guidance on medicinal gases – pharmaceutical information released for consultation july 2000

factor viii and ix products note for guidance on the clinical
core spc for human albumin adopted october 2000 note for guidance on the clinical investigation of human plasma derived factor viii and ix products released for consultation june 2000

ich q3c (m) maintenance document for guidance on impurities
stability testing: stability testing of existing active substances and related finished products

note for guidance on evaluation of anticancer medicinal products in man
note for guidance on evaluation of anticancer medicinal adopted may 2001 products in man

note for guidance on specifications: test procedures and acceptance criteria for
note for guidance on specifications: test procedures and acceptance criteria for herbal drugs, herbal drug preparations and herbal medicinal products released for consultation november 2000

note for guidance on clinical investigation of medicinal products for treatment of pain
note for guidance on clinical investigation of medicinal products for treatment of pain

immunoglobulin for intravenous and/ or intramuscular use note for guidance on the clinical
note for guidance on the clinical investigation of human anti-d immunoglobulin for intravenous and/or intramuscular use adopted june 2000

and immunosera for human use note for guidance on comparability of medicinal products containing
note for guidance on the production and quality control of animal immunoglobulins and immunosera for human use released for consultation january 2000

note for guidance on clinical investigation of medicinal products for the treatment of migraine.
note for guidance on clinical investigation of medical products cpmp blood product working party in the treatment of panic disorder

annex to note for guidance on stability testing of new active substances and medicinal products.
annex to note for guidance on stability testing of new active substances and medicinal products.

note for guidance on clinical investigation of medicinal products for the treatment and prevention of bipolar disorder
note for guidance on clinical investigation of medicinal products for the treatment and prevention of bipolar disorder